this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

Chemical Component Summary

NameFOSFOMYCIN
Identifiers[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid
FormulaC3 H7 O4 P
Molecular Weight138.06 g/mol
TypeNON-POLYMER
Isomeric SMILESC[C@@H]1O[C@@H]1P(O)(O)=O
InChIInChI=1S/C3H7O4P/c1-2-3(7-2)8(4,5)6/h2-3H,1H3,(H2,4,5,6)/t2-,3+/m0/s1
InChIKeyYMDXZJFXQJVXBF-STHAYSLISA-N

Chemical Details

Formal Charge0
Atom Count15
Chiral Atom Count2
Chiral AtomsC1,C2
Bond Count15
Aromatic Bond Count0
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00828 Different stereochemistry
NameFosfomycin
Groupsapproved
DescriptionAn antibiotic produced by Streptomyces fradiae. [PubChem]
Synonyms
  • (-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid
  • (1R,2S)-Epoxypropylphosphonic acid
  • (2R-cis)-(3-Methyloxiranyl)phosphonic acid
  • 1R-cis-(1,2-Epoxypropyl)phosphonic acid
  • cis-(1R,2S)-Epoxypropylphosphonic acid
Salts
  • Fosfomycin calcium monohydrate
  • Fosfomycin disodium
  • Fosfomycin tromethamine
Brand Names
  • Monurol
  • Veramina
Affected OrganismEnteric bacteria and other eubacteria
IndicationFor the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of <i>Escherichia coli</i> and <i>Enterococcus faecalis</i>.
PharmacologyFosfomycin is a broad spectrum antibiotic that concentrates in kidney and bladder and is used to treat uncomplicated urinary tract infections. Fosfomycin also reduces nephrotoxicity and ototoxicity of platinum-containing anti-tumor agents.
Mechanism of actionFosfomycin is a phosphoenolpyruvate analogue produced by Streptomyces that irreversibly inhibits enolpyruvate transferase (MurA), which prevents the formation of N-acetylmuramic acid, an essential element of the peptidoglycan cell wall.
Route of administrationOral
Categories
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antibacterials for Systemic Use
  • Antiinfectives for Systemic Use
  • Chemical Actions and Uses
ATC-CodeJ01XX01
AHFS-Code08:36.00
CAS number23155-02-4

Drug Targets

NameSequence SearchPharmacological ActionActions
UDP-N-acetylglucosamine 1-carboxyvinyltransferaseMDKFRVQGPTKLQGEVTISGAKNAALPILFAALLAEEPVEIQNVPKLKDV...yesinhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682